In the last blog, we discussed the Drug Supply Chain Security Act. Today we want to discuss the change that is effective on 11/27/2023, the Enhanced Drug Distribution Security (EDDS). We will review what is in place today and how
After our last blog on PRS Partners with NPTA to Expand Independent Pharmacies Role in Delivering COVID-19 Vaccines and Testing Services (12/14/2020) (link below), we wanted to go over the general requirements outlined in the Department of Health and Human
Attention CLIA Certified Pharmacies: Over ten thousand Pharmacies have a CLIA Certificate of Waiver. Most of these Pharmacies have been providing CLIA waived testing as a cash service only, increasing revenue and helping to offset dropping reimbursements and DIRS. But
COVID-19. We all know what it is by now – no need to explain further. For specific information about COVID-19 from the experts, please visit the CDC website, Coronavirus Disease 2019 (COVID-19). In this blog, we will cover regulations and
The Food and Drug Administration said Tuesday it has sent a warning letter to drug distributor McKessson for allegedly shipping “illegitimate” opioid products and failing to properly handle and investigate the incidents. Specifically, the FDA is accusing McKesson of failing
The State Assets Management Center under the State Committee of Uzbekistan on Assistance to Privatized Enterprises and Development of Competition and the American company United Investment Healthcare Group signed an agreement on the transfer of the Dori-Darmon pharmaceutical company to
Knowing what is happening in the world of HIPAA “mistakes” can be beneficial to you as a pharmacy owner. HHS press releases tell the following stories: Mobile devices, full of unencrypted records, are being stolen. A USB drive was taken
